Allylphenols as a new class of human 15-lipoxygenase-1 inhibitors.
Drug Dev Res
; 82(2): 259-266, 2021 04.
Article
em En
| MEDLINE
| ID: mdl-33022099
In this study, a series of mono- and diallylphenol derivative were designed, synthesized, and evaluated as potential human 15-lipoxygenase-1 (15-hLOX-1) inhibitors. Radical scavenging potency of the synthetic allylphenol derivatives was assessed and the results were in accordance with lipoxygenase (LOX) inhibition potency. It was found that the electronic natures of allyl moiety and para substituents play the main role in radical scavenging activity and subsequently LOX inhibition potency of the synthetic inhibitors. Among the synthetic compounds, 2,6-diallyl-4-(hexyloxy)phenol (42) and 2,6-diallyl-4-aminophenol (47) showed the best results for LOX inhibition (IC50 = 0.88 and 0.80 µM, respectively).
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fenóis
/
Araquidonato 15-Lipoxigenase
/
Inibidores de Lipoxigenase
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article